Looking for ways to advocate? Check out our current advocacy opportunities below! If none are available right now, explore our Advocate’s Starter Guide to get started on making an impact.
Support Expanded Access to Pritelivir: Comment on the FDA Petition
Pritelivir is a promising antiviral being developed by AiCuris. Early studies suggest it may be more effective than traditional antivirals at reducing herpes outbreaks and viral shedding. However, it is currently only available to immunocompromised patients through an early access program (learn more here).
Advocates in the herpes community have submitted a petition to the FDA, urging expanded access to Pritelivir. Now, your voice is needed!
Tell the FDA what broader access to Pritelivir would mean for you. You can share your story—publicly or anonymously—and help make a difference.
Follow this link and click the comment button in the top left corner to share your thoughts.
WHO News Call to Action
On December 11th, 2024, the World Health Organization (WHO) released a new study on the burden of genital herpes globally. According to new estimates, more than 1 in 5 people between 15-49 are living with genital herpes infections. That means 1 person every second – 42 million people annually – is estimated to acquire a new genital herpes infection.
Click here to email the WHO organization.
Click here to email your elected representatives.
Click here to email the CDC.
Policies for the People Campaign
The “Policies for the People” forum is a platform for community members to discuss policy ideas, share personal experiences, and propose changes to address pressing issues. While it aims to gather community input and advocate for policy changes, there is no direct guarantee that proposals on the site will be reviewed or acted upon by government officials. However, initiatives with strong community support may be elevated for broader advocacy efforts or presented to policymakers. The more votes the better!